M Rushton1, A Kwong1, H Visram1, N Graham2, W Petrcich3, S Dent2. 1. University of Ottawa, Ottawa, ON. 2. The Ottawa Hospital Cancer Centre, Ottawa, ON. 3. The Ottawa Hospital Research Institute, Ottawa, ON.
Abstract
BACKGROUND: Male breast cancer (bc) is a rare disease, and the availability of information on treatment outcomes is limited compared with that for female bc. The objective of the present study was to compare disease-free (dfs) and overall survival (os) for men compared with women having early-stage bc. METHODS: This retrospective case-control study compared men and women treated for stage 0-iiib bc at a single institution between 1981 and 2009. Matching was based on age at diagnosis, year of diagnosis, and stage. Treatment, recurrence, and survival data were collected. Kaplan-Meier analysis was used to calculate os and dfs. RESULTS: For the 144 eligible patients (72 men, 72 women), median age at diagnosis was 66.5 years. Treatments included mastectomy (72 men, 38 women), radiation (29 men, 44 women), chemotherapy (23 men, 20 women), and endocrine therapy (57 men, 57 women). Mean dfs was 127 months for women compared with 93 months for men (p = 0.62). Mean os was 117 months for women compared with 124 months for men (p = 0.35). In multivariate analysis, the only parameter that affected both dfs and os was stage at diagnosis. CONCLUSIONS: This case-control study is one of the largest to report treatment outcomes in early-stage male bc patients treated in a non-trial setting. Male patients received systemic therapy that was comparable to that received by their female counterparts, and they had similar os and dfs. These results add to current evidence from population studies that male sex is not a poor prognostic factor in early-stage breast cancer.
BACKGROUND:Male breast cancer (bc) is a rare disease, and the availability of information on treatment outcomes is limited compared with that for female bc. The objective of the present study was to compare disease-free (dfs) and overall survival (os) for men compared with women having early-stage bc. METHODS: This retrospective case-control study compared men and women treated for stage 0-iiib bc at a single institution between 1981 and 2009. Matching was based on age at diagnosis, year of diagnosis, and stage. Treatment, recurrence, and survival data were collected. Kaplan-Meier analysis was used to calculate os and dfs. RESULTS: For the 144 eligible patients (72 men, 72 women), median age at diagnosis was 66.5 years. Treatments included mastectomy (72 men, 38 women), radiation (29 men, 44 women), chemotherapy (23 men, 20 women), and endocrine therapy (57 men, 57 women). Mean dfs was 127 months for women compared with 93 months for men (p = 0.62). Mean os was 117 months for women compared with 124 months for men (p = 0.35). In multivariate analysis, the only parameter that affected both dfs and os was stage at diagnosis. CONCLUSIONS: This case-control study is one of the largest to report treatment outcomes in early-stage male bc patients treated in a non-trial setting. Male patients received systemic therapy that was comparable to that received by their female counterparts, and they had similar os and dfs. These results add to current evidence from population studies that male sex is not a poor prognostic factor in early-stage breast cancer.
Entities:
Keywords:
Male breast cancer; outcomes comparison; treatment
Authors: Robert Kornegoor; Anoek H J Verschuur-Maes; Horst Buerger; Marieke C H Hogenes; Peter C de Bruin; Joost J Oudejans; Petra van der Groep; Bernd Hinrichs; Paul J van Diest Journal: Mod Pathol Date: 2011-11-04 Impact factor: 7.842
Authors: Holm Eggemann; Atanas Ignatov; Bobbie J Smith; Udo Altmann; Gunter von Minckwitz; Freidrich W Röhl; Mark Jahn; Serban-Dan Costa Journal: Breast Cancer Res Treat Date: 2012-12-09 Impact factor: 4.872
Authors: S Thorlacius; L Tryggvadottir; G H Olafsdottir; J G Jonasson; H M Ogmundsdottir; H Tulinius; J E Eyfjord Journal: Lancet Date: 1995-08-26 Impact factor: 79.321
Authors: Edward Yu; Larry Stitt; Olga Vujovic; Kurian Joseph; Avi Assouline; Jawaid Younus; Francisco Perera; Patricia Tai Journal: Cureus Date: 2015-10-16